Breast tumor kinase (Brk/PTK6) is a mediator of hypoxia-associated breast cancer progression

Basal-type triple-negative breast cancers (TNBC) are aggressive and difficult to treat relative to luminal type breast cancers. TNBC often express abundant Met receptors and are enriched for transcriptional targets regulated by hypoxia inducible factor 1-alpha (HIF-1α), which independently predicts...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Regan Anderson, Tarah M., Peacock, Danielle L., Daniel, Andrea R., Hubbard, Gregory K., Lofgren, Kristopher A., Girard, Brian J., Schörg, Alexandra, Hoogewijs, David, Wenger, Roland H., Seagroves, Tiffany N., Lange, Carol A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3820501/
https://ncbi.nlm.nih.gov/pubmed/23928995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-13-0523
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak